Novales

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Novales

Quick Facts: Novales

Property Description
Active ingredient Pravastatin sodium
Form Oral tablet (Film-coated)
Pharmacological class HMG-CoA reductase inhibitor (Statin)
Common use Metabolic management of blood lipids
Origin Semi-synthetic compound

Identity and Pharmacological Class

Novales is a specific brand of a prescription-only pharmaceutical product that contains the active chemical entity Pravastatin sodium (Pravastatin). It is classified as an HMG-CoA reductase inhibitor, known informally as a statin. This classification is clinically recognized for its essential role in modifying the metabolic processes involved in cholesterol production. A distinctive feature of Pravastatin within the statin class is its relatively high hydrophilicity, which pharmacological studies indicate limits its penetration into non-hepatic tissues, concentrating its action primarily within the liver. This feature is often highlighted as a point of pharmacological differentiation.

Composition and General Purpose

Novales is manufactured as a single-component oral tablet and is not a combination product. Its composition centers on the Pravastatin sodium active agent, a semi-synthetic compound derived through microbial transformation. The tablets are manufactured as film-coated for reliable oral administration, ensuring consistent absorption. The overarching purpose of Novales is to serve as an antihyperlipidemic drug, functioning to manage blood lipid levels. This mechanism involves selectively blocking the HMG-CoA reductase enzyme in the liver, which directly reduces the production of cholesterol, thereby helping regulate the overall lipid profile.

What side effects are possible with Novales?

Possible Side Effects and Safety Information

Regulatory documents classify the potential adverse effects of Novales (Pravastatin) based on their observed frequency in clinical studies. These effects are grouped by the affected System-Organ Class (SOC), which includes reactions within the Nervous System, Gastrointestinal System, and Musculoskeletal and Connective Tissues.

The officially documented adverse reactions span several frequency categories. Common effects, reported in up to 1 in 100 people, often involve headache, dizziness, fatigue, and gastrointestinal issues such as nausea and flatulence. Uncommon effects may include certain sleep disturbances, visual disturbances, hair loss, and various skin reactions like rash and pruritus.

Of particular importance is the category of Rare or serious adverse reactions. These include severe skeletal muscle breakdown known as Rhabdomyolysis, which carries a documented risk of potentially leading to renal failure. Other rare, but serious, effects officially listed are Pancreatitis and certain forms of Hepatitis leading to hepatic failure. The label also documents severe hypersensitivity reactions.

Safety limitations and constraints are defined for specific patient populations. Pravastatin is contraindicated in individuals with active liver disease or persistent, unexplained elevations of liver enzymes. Furthermore, the medicine is contraindicated during pregnancy and lactation. The risk of serious muscle events, such as rhabdomyolysis, is officially noted to be increased in certain situations, including in older adults and when used concomitantly with specific medications like fibrates or systemic fusidic acid, as stated in the official prescribing information.

Overdose and Emergency Response

Overdose and when to seek help

This section reflects the official regulatory guidance on overdosage with Pravastatin sodium (Novales), strictly based on governmental documentation.

Overdose scope Regulatory Statement
Documented overdose presentations Clinical experience with acute overdosage is limited. No specific or characteristic symptoms were identified in trials that employed doses up to 240 mg per day.
Physiological systems affected (as stated in label) Acute, massive overdose is not generally associated with specific life-threatening clinical manifestations documented in official labeling.
Dose-related or exposure-related factors (if applicable) Clinical trials included subjects receiving high-dose exposures without reported unique or acute signs.
Population-specific overdose notes (if applicable) No specific population-based considerations for acute management are defined in the regulatory overdose sections.

Overdose classifications (high-level) Regulatory Statement
Severity classification (as defined in official documents) Not assigned a specific severe clinical outcome from acute overdosage in documented experience.
Overdose-context constraints (as defined in official documents) No specific antidote for Pravastatin overdose is known.

Resulting Overdose Structure and Emergency Action

  • The primary regulatory action required is to seek immediate medical attention or contact a Poison Control Center if an overdose is suspected.
  • Management should be symptomatic and supportive, as no specific antidote is known to counteract the effects of overdosage.
  • Hospital observation and continuous monitoring are indicated as part of general supportive care.

The official overdose profile for Novales emphasizes the limited clinical experience and the absence of specific acute symptoms, thereby prioritizing necessary procedural responses. Regulators mandate that users seek immediate medical attention to ensure prompt supportive care and monitoring, since no specific pharmaceutical agent is available for reversal.

Therapeutic Uses of Novales

Novales is a treatment used in situations involving certain distressing symptoms, applicable across therapeutic domains where additional symptomatic support is needed. The active component is applied in addressing symptoms related to inflammatory or irritative states. This class of medication is commonly used to help with temporary relief of minor aches and pains.

This is commonly used to help with managing symptom clusters that may become intense or disruptive, such as those related to headache, muscular aches, backache, toothache, and menstrual cramps. It is considered relevant in conditions presenting with acute episodes, and may also assist with managing symptoms related to systemic imbalance, such as fever. Overall, the medication provides supportive relief when symptoms interfere with daily comfort, assisting with maintaining functional stability. It contributes to easing the overall symptom load and may help patients cope more steadily with symptom fluctuations.


Quick Fact: Relevant for Easing Physical Discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Novales?

This section describes the specific population eligibility rules for Novales (Pravastatin sodium) as defined by official regulatory bodies.


Absolute Contraindications

Novales must not be used by specific populations as stated in the label:

  • Active Liver Disease: Use is prohibited in patients with active liver disease or unexplained, persistent elevation of liver enzymes.
  • Reproductive Status: The medicine is contraindicated for women who are pregnant or may become pregnant and for nursing mothers (breastfeeding women).
  • Hypersensitivity: Patients with a known allergy to Pravastatin sodium or any of the inactive ingredients.

Age and Condition Restrictions

Eligibility for other groups is conditional or requires caution:

  • Pediatric Use: Use is generally not recommended in children under 8 years of age. For children and adolescents aged 8 years and older, use is restricted to those diagnosed with Heterozygous Familial Hypercholesterolemia (HeFH).
  • Organ Impairment: Patients with severe renal impairment or those aged 65 years or greater require careful monitoring due to an increased risk of muscle-related issues.
  • Comorbidities: Caution is required for individuals with predisposing factors for muscle toxicity, such as uncontrolled hypothyroidism or a history of hereditary muscular disorders.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Novales (Pravastatin) interacts with several medicinal products and substances, primarily through altering the amount of drug in the bloodstream or by combining effects that raise the risk of muscle-related disorders. The official regulatory documentation outlines specific constraints for these combinations.

Exposure-Altering Interactions

Co-administration with Cyclosporine causes a marked increase in Pravastatin plasma levels due to inhibition of hepatic uptake transporters, which significantly elevates the documented risk of severe muscle-related events. Similarly, Macrolide Antibiotics (such as Clarithromycin) and Azole Antifungals can lead to moderately increased Pravastatin concentrations.

Pharmacodynamic and Toxicity Risk

The combination with Fibrates (like Gemfibrozil or Fenofibrate) results in both increased Pravastatin levels and a documented additive pharmacological effect that enhances the risk of muscle toxicity, including myopathy and rhabdomyolysis. The use of Colchicine is also formally associated with this increased risk of muscle disorders.

Administration Timing Rules

To prevent reduced absorption, Bile Acid Sequestrants (such as Cholestyramine or Colestipol) must be administered with strict timing separation. Pravastatin should be taken at least one hour before or four hours after the sequestrant.

Population Considerations

Official cautions exist for patients with existing hepatic or renal impairment, as their condition may lead to higher baseline Pravastatin exposure, thereby heightening the severity of co-administered drug interactions.

Mechanism of Action

1. Selective Blockade of Cholesterol Production

Novales (Pravastatin) functions as a selective, competitive, and reversible inhibitor of the HMG-CoA reductase enzyme within liver cells (hepatocytes). This interaction blocks the rate-limiting step of the mevalonate pathway, which prevents the liver from synthesizing its own cholesterol. This process directly results in a reduction of the intracellular cholesterol pool.


2. Enhanced Systemic Lipoprotein Clearance

This initial molecular action triggers a compensatory cascade: the internal cholesterol deficiency activates the Sterol Regulatory Element-Binding Proteins (SREBP) feedback mechanism. This causes an upregulation of LDL receptors on the hepatocyte surface. The resulting increase in receptor density accelerates the capture and catabolism of circulating LDL cholesterol from the plasma, leading to systemic lipoprotein clearance.


3. Hepatoselectivity and Vascular Signal Modulation

Pravastatin's hydrophilic nature necessitates active transport via the Organic Anion Transporting Polypeptide 1B1 ( OATP1B1), concentrating its inhibitory activity in the liver (hepatoselectivity). Furthermore, the inhibition of the mevalonate pathway limits the production of isoprenoid intermediates. This pleiotropic effect modulates GTP-binding proteins, which influences the signaling and function of the vascular endothelium.

Dosage and Administration Information

Official Administration Guidelines

Novales (Pravastatin sodium) is standardized for administration strictly via the oral route as a film-coated tablet, with strengths including 10 mg, 20 mg, 40 mg, and 80 mg. The medication is designated for once-daily intake and is not dependent on mealtimes, permitting consumption with or without food at any time of the day.

Dosing Regimens and Schedule

Treatment is typically initiated for adults at a dose of 40 mg once daily, and subsequent adjustments are based on therapeutic determination. Dose changes, if necessary, are evaluated and implemented at intervals of 4 weeks or longer following the previous dosage decision. The maximum standardized daily dose is 80 mg.

Standard usage includes specific dosing for certain populations. For patients with severe renal impairment, the initial dose is 10 mg once daily. Pediatric regimens also have defined limits: children aged 8 to 13 years have a maximum daily dose of 20 mg, while adolescents 14 to 18 years have a maximum of 40 mg.

Administration Context

This medication is intended to be used as an adjunct to a standard cholesterol-lowering diet. A key procedural constraint involves the timing of Novales relative to the administration of bile acid resins; Novales is taken either one hour or more before or at least four hours following the resin.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Novales

Evidence for Primary Prevention of Cardiovascular Events

Research has extensively examined the use of Novales in individuals who have elevated cholesterol but have no prior history of heart attack or other clinically evident Coronary Heart Disease (CHD). The main evidence in this area comes from large-scale, placebo-controlled Randomized Controlled Trials (RCTs). The studies were used in research exploring the incidence of a first major coronary event, such as a nonfatal heart attack or CHD-related death, in the observed populations. Researchers also monitored the need for cardiac procedures and stroke outcomes.

Studies described patterns observed over the typical five-year trial period, with reported measurements of a reduced rate of nonfatal heart attacks and CHD-related death when compared to the group that received an inactive substance (placebo). Furthermore, some research includes long-term observational follow-up spanning 10 to 20 years, and the patterns observed in the short-term trials were further examined in these extended follow-up settings. However, evidence is limited regarding the effect on overall death from all causes in the short- to intermediate-term follow-up.

Evidence for Secondary Prevention of Cardiovascular Events

Novales was evaluated in settings focused on secondary prevention—that is, in patients who have already been diagnosed with established Coronary Heart Disease (CHD), typically after experiencing a heart attack or unstable angina. This body of evidence is built upon several large-scale, multi-center RCTs and subsequent comprehensive analyses.

The major trials reported measurements of a reduced rate of subsequent coronary events and need for revascularization procedures in the treatment group compared to the placebo group over the study duration. One large trial specifically documented study findings related to the rate of all-cause mortality. Research describes patterns related to LDL-C levels from the beginning of the treatment period.

Studies on Modification of Blood Lipid Levels

Dedicated research examined the patterns related to various fats, or lipids, in the blood. These were often short-term clinical trials or studies designed to test different doses. The main outcomes were measured to quantify the specific changes in blood lipid biomarkers, including LDL-C, Total Cholesterol, and Triglycerides. The findings show patterns related to measurements of LDL-C that were lower than baseline, and this outcome often varied depending on the dose used.

What is Still Uncertain About Novales Research

Even with extensive research, the evidence base always has limitations. Comparative evidence is lacking from large-scale studies that directly compare Novales against every other medicine in the same class. There is limited information for long-term outcomes specifically concerning its effect on all-cause mortality over multiple decades. The initial study results apply only to the populations studied, meaning research is ongoing to fully understand the effects in populations with different ethnic backgrounds or those with specific rare medical conditions.

Frequently Asked Questions (FAQ)

Common questions about Novales (FAQ)

Q: What is the longest time someone is expected to take Novales?

Novales is typically prescribed as a long-term treatment for managing cholesterol levels. Studies have included observations spanning 10 to 20 years. Official guidance indicates that patients are advised not to discontinue treatment without prior consultation with a healthcare professional, as stopping may cause cholesterol levels to rise again.


Q: What are the signs that Novales is working for someone?

The primary way Novales works is by lowering LDL cholesterol (often referred to as 'bad' cholesterol). The therapeutic effect typically begins within about one week, with the full impact of a given dose visible in blood tests within four weeks. The medication's effect is measured by periodic lipid tests, which are conducted as part of the overall treatment regimen, rather than by noticeable physical signs.


Q: What kind of monitoring is usually required while on Novales?

Official prescribing information describes that liver enzyme tests are often assessed before starting therapy and as clinically indicated thereafter. Monitoring of Creatine Kinase ( CK) is generally not routine but may be considered if muscular symptoms develop or if predisposing factors exist. The frequency and type of monitoring are determined by the healthcare provider based on clinical status.


Q: What does the term 'contraindication' mean for Novales?

A contraindication is a medical term used in official documentation to describe a condition or factor that makes a particular treatment or procedure inadvisable. For Novales, absolute contraindications—meaning the use of the medicine is formally prohibited or restricted by regulatory agencies due to safety concerns—include active liver disease and pregnancy.


Q: How long does it take for Novales to start working?

According to official product information, the initial therapeutic response of Novales can be seen within approximately one week of starting treatment. The full effect of a specific dose is generally achieved after about four weeks of consistent use.


Q: Does Novales cause weight gain or loss?

Based on clinical trial data published in the official labeling, changes in body weight are not explicitly listed as a common or uncommon side effect directly caused by the medication. Most changes in weight while taking the drug are not typically attributed to Novales itself.


Q: Can I take Novales if I am taking vitamins or supplements?

While regulatory documents list specific interactions with certain drug classes, official documents emphasize the importance of disclosing all products used to a healthcare provider. This includes prescription and over-the-counter medicines, vitamins, minerals, and any herbal products. Specific combinations may require medical review to avoid potential complications.


Q: What happens if I miss a dose of Novales?

Official guidance provides standard instructions for managing a missed dose, typically advising patients not to double a dose and to resume the regular schedule. Detailed instructions for managing specific timing procedures are available in the patient information leaflet.


Q: Does Novales interact with common pain relievers like ibuprofen?

Regulatory information specifies interactions with several classes of drugs, such as fibrates and macrolide antibiotics. Common over-the-counter ( OTC) pain relievers are typically not listed as a contraindication or required timing separation. Nevertheless, official guidance indicates that all medicines taken should be disclosed to a healthcare provider, including OTC pain relievers.


Q: Is Novales addictive or habit-forming?

Novales (Pravastatin) is an HMG-CoA reductase inhibitor (a statin) and is not classified as an addictive substance or controlled drug. It is not associated with dependency or withdrawal symptoms if stopped under medical supervision.


Q: Are there any warnings about driving or operating machinery while on Novales?

Official information describes that the medication is not known to generally impair the ability to drive or operate machinery. However, since side effects like dizziness or blurred vision are reported, official guidance suggests patients use care when performing these activities.


Q: Is there a generic version of Novales available?

Yes, Novales is a brand name for the active ingredient Pravastatin. Official regulatory sources, such as the FDA Approved Drug Products listing, confirm that generic versions of Pravastatin sodium tablets are available.


Q: Can men and women use Novales differently?

Official regulatory labels include specific constraints for women of childbearing age due to potential hazards. The medicine is explicitly contraindicated (must not be used) for women who are pregnant, may become pregnant, or are nursing mothers. There are no equivalent sex-specific contraindications listed for men based on gender alone.


Q: Is it true that Novales has to be stopped slowly?

Official information states that the medicine is not associated with withdrawal symptoms, meaning a slow tapering is not mandated. However, discontinuation requires consultation with a healthcare professional to ensure proper management of cholesterol levels, as stopping the drug may cause cholesterol levels to increase again.


Q: Does Novales have any interaction with alcohol?

Regulatory warnings describe that consumption of substantial quantities of alcohol while using this medicine may increase the risk of liver damage. Official guidance advises patients to limit alcohol intake and disclose their drinking habits to a healthcare provider.


Q: What is the purpose of the boxed warning, if Novales has one?

Novales (Pravastatin) does not carry an FDA Boxed Warning (often called a 'Black Box Warning') in its regulatory label. Warnings related to serious risks, such as potential muscle or liver side effects, are detailed in the standard Warnings and Precautions sections of the official prescribing information.


Q: How is Novales removed from the body?

Pharmacokinetic data from the official label indicates that the active substance, Pravastatin, is primarily eliminated from the body through bile and subsequently via the feces. A smaller fraction is removed through the urine.


Q: Can Novales affect blood pressure?

Novales is primarily a drug for managing blood lipids (fats) and is not approved or commonly used for treating high blood pressure (hypertension). Changes to blood pressure are not listed among the common or uncommon side effects in the official regulatory label.


Q: Where can I find the official package insert for Novales?

The full official regulatory information, including the medication's Package Insert (Labeling), is public information. This documentation can be found online through government-run sources such as the DailyMed and Drugs@FDA websites.


Q: Can Novales be used by people who are lactose intolerant?

Official documentation indicates that Novales (Pravastatin) tablets contain lactose as an inactive ingredient, or excipient. Patients with known sensitivities or rare hereditary conditions such as galactose intolerance or lactase deficiency are advised to seek information from their prescribing doctor due to the presence of lactose.


Q: Can Novales be taken with cold or flu medicine?

The official label does not typically list interactions for general over-the-counter ( OTC) cold and flu medicines. However, official guidance advises that patients disclose all over-the-counter ( OTC) products, including cold and flu medicines, to a healthcare provider to allow for a full review of potential interactions.


Q: How quickly do the side effects of Novales usually go away?

The duration of side effects is generally not specified in regulatory documents, although many common side effects are described as transient. Official safety information advises that the development of serious symptoms, such as unexplained muscle pain or signs of liver issues, requires immediate medical review.


Q: Is it okay to stop Novales suddenly?

Official guidance indicates that although the medicine does not have withdrawal symptoms, discontinuation of treatment should always be discussed with a doctor to ensure appropriate continued management of the patient's condition, as cholesterol levels may rise again.


Q: Can Novales be taken with herbal teas?

Official information stresses the importance of disclosing all herbal products and supplements used to a healthcare provider. While specific interactions with herbal teas are generally not listed in the regulatory label, disclosure allows for a proper evaluation of potential risks.


Q: Does Novales interact with birth control pills?

Regulatory documents and interaction studies have not reported a specific interaction between Pravastatin and hormonal contraceptives, such as birth control pills. The medication is not expected to affect the effectiveness of these contraceptives.


Q: What is the half-life of Novales?

Pharmacokinetic data from the official regulatory label indicates that the mean elimination half-life—the time it takes for half of the drug to be removed from the body—is approximately 1.8 hours to 3.5 hours.


Q: Why is Novales considered a controlled substance (if applicable)?

Pravastatin is an HMG-CoA reductase inhibitor (statin) and is not currently designated or scheduled as a controlled substance by the US Drug Enforcement Administration ( DEA) or other major international regulatory bodies. It is an oral prescription medication.

How should Novales be stored and disposed of?

The official requirements for Novales (Pravastatin sodium) storage and disposal are defined by regulatory documents to ensure product stability and public safety.

Storage & Disposal Profile

Requirement Area Official Labeled Condition
Storage Temperature Controlled Room Temperature (20^circC to 25^circC or 68^circF to 77^circF). Excursions are permitted between 15^circC and 30^circC (59^circF and 86^circF).
Protection Must be kept tightly closed to protect from moisture and light; store away from excess heat.
Child Safety The medication must be stored out of the reach of children.
Disposal Follow the primary official guideline: dispose of unused or expired product through an authorized drug take-back program.
Environmental Rule If a take-back is unavailable, mix with an undesirable substance and seal for household trash; do not flush down the toilet or drain.

Adherence to these conditions maintains the product's stability until the expiry date.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Novales found in:

A-Z Index: